---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-316225"
form_type: "8-K"
ticker: "MD"
cik: "0000893949"
company_name: "Pediatrix Medical Group, Inc."
filed_at: "2026-07-24T21:00:13+00:00"
generated_at: "2026-07-24T21:02:38.409210+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Pediatrix Medical Group GC Mary Ann Moore to depart Oct 31; David Haddock appointed successor

## Summary
- Mary Ann Moore will transition to advisory role until October 31, 2026, then leave the company.
- Separation agreement with PMG Services; termination without cause triggers benefits under employment agreement.
- David Haddock appointed Executive Vice President, General Counsel and Secretary effective immediately.

## SEC filing metadata
- accession: 0001193125-26-316225
- form_type: 8-K
- ticker: MD
- cik: 0000893949
- company_name: Pediatrix Medical Group, Inc.
- filed_at: 2026-07-24T21:00:13+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/893949/000119312526316225/0001193125-26-316225-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/893949/000119312526316225/md-20260721.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-316225
- JSON: https://secwatch.observer/filing/0001193125-26-316225.json
- Plain text: https://secwatch.observer/filing/0001193125-26-316225.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.